Jeff Yass’s Bone Biologics BBLG Stock Holding History
Bought
Maintained
Sold
Other funds holding BBLG
Jeff Yass's BBLG Position: Q3 2026 in Review
Jeff Yass opened a new position in Bone Biologics (BBLG) in Q3 2026: 11,970 shares worth $5.94K. The stake represents ﹤0.01% of the portfolio and ranks #13277 among its holdings. This is a return to the name: Jeff Yass previously reported a position in BBLG as recently as Q4 2022.
Jeff Yass first reported a position in BBLG in Q4 2022 and has held it in 2 quarters since. The position peaked at $10.7K in Q4 2022. 8 funds tracked by Wall St. Rank hold BBLG as of Q3 2026.
- Jeff Yass held 11,970 shares of Bone Biologics worth $5.94K as of Q3 2026.
- Bone Biologics was a new Jeff Yass position in Q3 2026.
- Bone Biologics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13277 holding.
- Jeff Yass first reported a position in Bone Biologics in Q4 2022 and has held it in 2 quarters since.
- Jeff Yass's Bone Biologics position peaked at $10.7K in Q4 2022.
- 8 funds tracked by Wall St. Rank held Bone Biologics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.